Hydroxycarbamide alters erythroid gene expression in children with sickle cell anaemia.
about
Current and future alternative therapies for beta-thalassemia majorLIN28A expression reduces sickling of cultured human erythrocytes.Hydroxyurea treatment in β-thalassemia patients: to respond or not to respond?Variation in Gamma-Globin Expression before and after Induction with Hydroxyurea Associated with BCL11A, KLF1 and TAL1.Emerging science of hydroxyurea therapy for pediatric sickle cell disease.Individualizing fetal hemoglobin augmenting therapy for β-type hemoglobinopathies patients.Nucleotide Pool Depletion Induces G-Quadruplex-Dependent Perturbation of Gene Expression.Fetal hemoglobin in sickle cell anemia: The Arab-Indian haplotype and new therapeutic agents.Hydroxyurea responsiveness in β-thalassemic patients is determined by the stress response adaptation of erythroid progenitors and their differentiation propensity.In Vitro Hb Production in B-thalassemia Patients Is Not a Predictor of Clinical Responsiveness to HydroxyureaEfficacy of fixed low dose hydroxyurea in Indian children with sickle cell anemia: a single centre experience.Genomic variation in the MAP3K5 gene is associated with β-thalassemia disease severity and hydroxyurea treatment efficacy.Genomic variants in the ASS1 gene, involved in the nitric oxide biosynthesis and signaling pathway, predict hydroxyurea treatment efficacy in compound sickle cell disease/β-thalassemia patients.The role of BCL11A and HMIP-2 polymorphisms on endogenous and hydroxyurea induced levels of fetal hemoglobin in sickle cell anemia patients from southern Brazil.Beneficial Effect of Low Fixed Dose of Hydroxyurea in Vaso-occlusive Crisis and Transfusion Requirements in Adult HbSS Patients: A Prospective Study in a Tertiary Care Center
P2860
Q26750906-1BCDFFCD-DE1B-435E-8CC5-426E936C6B91Q34134379-C8D6CE8B-9E95-4B8D-95D3-2B7121A52FB0Q34322542-D2FF33D1-9156-4EF0-B4BF-9295BCB6D158Q35656305-B4C6250A-2339-4B15-973F-7749D1F18B88Q38164192-802964B2-2F0F-44BA-A4AA-F0D8092AD3ECQ38243173-0072E7D8-8A7D-409F-B411-E5C2A0860240Q38810336-ACC14B54-38E7-4CF5-815C-12560900AD28Q39453785-685C758E-A7D4-4613-A687-8CFED4E80EA0Q40245190-4D853924-61D0-448A-82BA-2BB2FC6EDC32Q41466551-1A3F4197-2382-4F3E-B9BD-2499C173CEF0Q46075053-373FDE7D-EC9D-4FB3-B452-0BDD6617F926Q46906091-37801BA3-AA97-4B19-A6DD-6D63F5E19C1EQ52884101-8C2D78A4-3996-4518-9E73-9B975987B425Q55344926-47EC8556-A199-4D55-B395-9C5C15C76320Q56559475-58E5F9CD-0DF2-4C50-ADBE-CA0249E8D352
P2860
Hydroxycarbamide alters erythroid gene expression in children with sickle cell anaemia.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Hydroxycarbamide alters erythroid gene expression in children with sickle cell anaemia.
@en
Hydroxycarbamide alters erythroid gene expression in children with sickle cell anaemia.
@nl
type
label
Hydroxycarbamide alters erythroid gene expression in children with sickle cell anaemia.
@en
Hydroxycarbamide alters erythroid gene expression in children with sickle cell anaemia.
@nl
prefLabel
Hydroxycarbamide alters erythroid gene expression in children with sickle cell anaemia.
@en
Hydroxycarbamide alters erythroid gene expression in children with sickle cell anaemia.
@nl
P2093
P2860
P1476
Hydroxycarbamide alters erythroid gene expression in children with sickle cell anaemia.
@en
P2093
Amy C Kimble
Banu Aygun
Geoffrey A Neale
Jane S Hankins
Jonathan M Flanagan
Nicole A Mortier
Russell E Ware
Shirley Steward
Thad A Howard
P2860
P304
P356
10.1111/J.1365-2141.2012.09061.X
P407
P577
2012-02-24T00:00:00Z